Gilead Sciences, Inc. vs Enbridge Inc.
μκ°μ λ°λ₯Έ μκ°μ΄μ‘ λΉκ΅
Gilead Sciences, Inc.
$163.0B
μμ #109
Enbridge Inc.
$167.5B
μμ #106
μκ°μ λ°λ₯Έ μκ°μ΄μ‘
μ£Όμ μκ°
- Gilead Sciences, Inc.μ΄(κ°) 2005λ κΉμ§ Enbridge Inc.μ(λ₯Ό) μΆμνμ΅λλ€
- Enbridge Inc.μ΄(κ°) 2010λ κΉμ§ Gilead Sciences, Inc.μ(λ₯Ό) μΆμνμ΅λλ€
- Gilead Sciences, Inc.μ΄(κ°) 2013λ κΉμ§ Enbridge Inc.μ(λ₯Ό) μΆμνμ΅λλ€
- Enbridge Inc.μ΄(κ°) 2026λ κΉμ§ Gilead Sciences, Inc.μ(λ₯Ό) μΆμνμ΅λλ€
μ°λλ³ λΉκ΅
| μ°λ | Gilead Sciences, Inc. | Enbridge Inc. | μ λ |
|---|---|---|---|
| 2026 | $163.0B | $167.5B | Enbridge Inc. |
| 2025 | $150.5B | $102.0B | Gilead Sciences, Inc. |
| 2024 | $110.0B | $89.4B | Gilead Sciences, Inc. |
| 2023 | $92.6B | $65.2B | Gilead Sciences, Inc. |
| 2022 | $94.6B | $67.4B | Gilead Sciences, Inc. |
| 2021 | $76.4B | $59.1B | Gilead Sciences, Inc. |
| 2020 | $58.7B | $45.5B | Gilead Sciences, Inc. |
| 2019 | $63.0B | $53.7B | Gilead Sciences, Inc. |
| 2018 | $58.5B | $41.5B | Gilead Sciences, Inc. |
| 2017 | $65.0B | $45.3B | Gilead Sciences, Inc. |
| 2016 | $63.2B | $49.6B | Gilead Sciences, Inc. |
| 2015 | $87.4B | $38.8B | Gilead Sciences, Inc. |
| 2014 | $80.8B | $48.7B | Gilead Sciences, Inc. |
| 2013 | $64.4B | $36.8B | Gilead Sciences, Inc. |
| 2012 | $31.5B | $33.2B | Enbridge Inc. |
| 2011 | $17.6B | $28.6B | Enbridge Inc. |
| 2010 | $15.5B | $20.4B | Enbridge Inc. |
| 2009 | $18.6B | $17.1B | Gilead Sciences, Inc. |
| 2008 | $21.9B | $13.4B | Gilead Sciences, Inc. |
| 2007 | $19.7B | $13.1B | Gilead Sciences, Inc. |
| 2006 | $13.9B | $12.8B | Gilead Sciences, Inc. |
| 2005 | $11.3B | $11.2B | Gilead Sciences, Inc. |
| 2004 | $7.5B | $8.9B | Enbridge Inc. |
| 2003 | $6.2B | $7.7B | Enbridge Inc. |
| 2002 | $3.6B | $5.9B | Enbridge Inc. |
| 2001 | $3.5B | $5.8B | Enbridge Inc. |
| 2000 | $2.2B | $5.7B | Enbridge Inc. |
| 1999 | $1.5B | $3.6B | Enbridge Inc. |
| 1998 | $1.1B | $4.3B | Enbridge Inc. |
| 1997 | $1.0B | $3.8B | Enbridge Inc. |
| 1996 | $670.1M | $2.2B | Enbridge Inc. |
| 1995 | $857.7M | $1.7B | Enbridge Inc. |